The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation
暂无分享,去创建一个
G. Weinstein | A. Chalian | H. Chao | R. Cohen | J. Lukens | A. F. Ghiam | S. Swisher-McClure | A. Lin | J. Newman | C. Aggarwal | B. O'Malley | C. Rassekh | C. Schonewolf | J. Bauml | Erik X. Tan | Erik X Tan
[1] A. Ho,et al. Quantitative survival impact of composite treatment delays in head and neck cancer , 2018, Cancer.
[2] C. von Buchwald,et al. Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).
[3] T. Day,et al. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer , 2017, Cancer.
[4] F. Faraji,et al. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma , 2017, Cancer and Metastasis Reviews.
[5] R. Mehra,et al. The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. , 2016, International journal of radiation oncology, biology, physics.
[6] G. Weinstein,et al. HPV‐related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery , 2016, Head & neck.
[7] E. Sturgis,et al. Epidemiology of HPV-associated oropharyngeal cancer. , 2014, Oral oncology.
[8] G. Weinstein,et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. , 2012, Archives of otolaryngology--head & neck surgery.
[9] L. Specht,et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[11] Jens Overgaard,et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M. van Glabbeke,et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.
[13] Lisa Barbera,et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Weber,et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck , 2002, Head and Neck.
[15] A. Garden,et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer , 2001 .
[16] B. Vikram,et al. Importance of the time interval between surgery and postoperative radiation therapy in the combined management of head & neck cancer. , 1979, International journal of radiation oncology, biology, physics.